Dark

CBIO
Crescent Biopharma, Inc. Common Stock
stock NASDAQ

Market Open

Jul 28, 2026 2:15:02 PM EDT

16.48USD-2.658%(-0.45)104,888

14.01Bid 18.96Ask 4.95Spread

Pre-market

0.00USD-100.000%(-16.30)0

After-hours

Jul 27, 2026 4:00:30 PM EDT

16.93USD+0.059%(+0.01)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

608.47M

CEO

Nassim Usman

Headquarters

South San Francisco, California, USA

Industry

Biotechnology

Next Earnings

Jul 30, 2026 (2d)

Last Dividend

Aug 20, 20151.649

Last Split

Jun 16, 20251for100reverse

CORT AZN BMY JNJ PFE MRK ABBV ADMS ZGNX XLV

CBIO Stats

Avg. Vol. 10 Day

569,047

Avg. Vol. 30 Day

433,143

Employees

Market Cap

608,465,528

Shares Out.

36,962,721

On/Off Exchange

63%/37%

6 Month Beta

0.72

1 Year Beta

0.67

2 Year Beta

1.28

3 Year Beta

0.80

52 Week Low

8.72

52 Week High

27.41

SMA50

17.82

SMA200

14.80

1 Week

-1.07%

1 Month

-8.55%

3 Month

-31.30%

6 Month

+53.42%

1 Year

+24.24%

2 Year

+114.64%

5 Year

-74.54%

Profile

catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.

CBIO Stock Summary

Crescent Biopharma, Inc. Common Stock (NASDAQ:CBIO) stock price today is $16.48, and today's volume is 104,888. CBIO is down -2.658% today. The 30 day average volume is 433,143. CBIO market cap is 608.47M with 36,962,721 shares outstanding.